Could a popular Weight-Loss drug also help paralyzed patients manage diabetes?
Disease control
Recruiting now
This study is testing if the diabetes and weight-loss drug semaglutide (Ozempic) works well for people who have both a spinal cord injury and type 2 diabetes. About 50 participants will receive either the real drug or a placebo injection once a week for 24 weeks. Researchers will…
Phase: PHASE4 • Sponsor: Marzieh Salehi • Aim: Disease control
Last updated Apr 02, 2026 08:57 UTC